4.6 Article

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients

Related references

Note: Only part of the references are listed.
Review Oncology

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

Midhun Malla et al.

Summary: Circulating tumor DNA (ctDNA) plays a crucial role in the personalized management of colorectal cancer, serving as a promising prognostic and predictive biomarker for detecting disease residual, early recurrence, and molecular profiling. Prospective studies focusing on minimal residual disease (MRD) are essential for further understanding the clinical applications of ctDNA.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Oncology

Clinical application of circulating tumor DNA in breast cancer

Jeffrey Chun Hin Chan et al.

Summary: ctDNA has diverse applications in breast cancer management, including real-time monitoring of tumor response, detection of drug-resistant clones, and assessment of dynamic variations in tumor mutational landscape.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Biochemical Research Methods

Detecting ultralow-frequency mutations by Duplex Sequencing

Scott R. Kennedy et al.

NATURE PROTOCOLS (2014)

Review Multidisciplinary Sciences

Clonal evolution in cancer

Mel Greaves et al.

NATURE (2012)

Letter Biotechnology & Applied Microbiology

Integrative genomics viewer

James T. Robinson et al.

NATURE BIOTECHNOLOGY (2011)

Article Multidisciplinary Sciences

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

Cassandra B. Jabara et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)